Sickle-cell anemia treatment

NEW YORK, July 24 (Praxis Press) Previous reports have documented that sodium cromoglicate has antisickling activity in vitro. Toppet and colleagues studied this antisickling activity in sickle-cell patients given sodium cromoglicate by inhalation or nasal route. Both treatments significantly decreased the percentage of sickle cells in venous blood; this effect was largely retained when the blood was deoxygenated. Sodium cromoglicate may be a clinically useful antisickling drug that has the adde

July 25, 2000

NEW YORK, July 24 (Praxis Press) Previous reports have documented that sodium cromoglicate has antisickling activity in vitro. Toppet and colleagues studied this antisickling activity in sickle-cell patients given sodium cromoglicate by inhalation or nasal route. Both treatments significantly decreased the percentage of sickle cells in venous blood; this effect was largely retained when the blood was deoxygenated. Sodium cromoglicate may be a clinically useful antisickling drug that has the added benefits of low toxicity and low cost.

Popular Now

  1. A Newly Identified Species Represents Its Own Eukaryotic Lineage
  2. Telomere Length and Childhood Stress Don’t Always Correlate
  3. Optogenetic Therapies Move Closer to Clinical Use
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech